AlphaCN
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AlphaCN, covering 2025-01-13 to 2025-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) [Phase 1, Phase 2]